These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9815278)

  • 41. Analysis of DNA content in multidrug-resistant cells by image and flow cytometry.
    Palissot V; Liautaud-Roger F; Carpentier Y; Dufer J
    Cell Prolif; 1996 Oct; 29(10):549-59. PubMed ID: 9051118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
    Tapiero H; Nguyen-Ba G; Lampidis TJ
    Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line.
    Bennis S; Ichas F; Robert J
    Int J Cancer; 1995 Jul; 62(3):283-90. PubMed ID: 7628869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells.
    Shen F; Chu S; Bence AK; Bailey B; Xue X; Erickson PA; Montrose MH; Beck WT; Erickson LC
    J Pharmacol Exp Ther; 2008 Jan; 324(1):95-102. PubMed ID: 17947497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells.
    Muller C; Goubin F; Ferrandis E; Cornil-Scharwtz I; Bailly JD; Bordier C; Bénard J; Sikic BI; Laurent G
    Mol Pharmacol; 1995 Jan; 47(1):51-6. PubMed ID: 7838133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can cytotoxic activity of anthracyclines be related to DNA damage?
    Nishiyama M; Horichi N; Mazouzi Z; Bungo M; Saijo N; Tapiero H
    Anticancer Drug Des; 1990 Feb; 5(1):135-9. PubMed ID: 2317255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrastructural changes related to multidrug resistance in CEM cells: role of cytoplasmic vesicles in drug exclusion.
    Bobichon H; Colin M; Depierreux C; Liautaud-Roger F; Jardillier JC
    J Exp Ther Oncol; 1996 Jan; 1(1):49-61. PubMed ID: 9414388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective determination of the doxorubicin content of individual acidic organelles in impure subcellular fractions.
    Chen Y; Walsh RJ; Arriaga EA
    Anal Chem; 2005 Apr; 77(8):2281-7. PubMed ID: 15828758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intracellular localization of the antitumour drug adriamycin in living cultured cells: a confocal microscopy study.
    Meschini S; Molinari A; Calcabrini A; Citro G; Arancia G
    J Microsc; 1994 Dec; 176(Pt 3):204-10. PubMed ID: 7869363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole.
    Desai PB; Duan J; Sridhar R; Damle BD
    Methods Find Exp Clin Pharmacol; 1997 May; 19(4):231-9. PubMed ID: 9228648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The nuclear membrane in multidrug resistance: microinjection of epirubicin into bladder cancer cell lines.
    Featherstone JM; Speers AG; Lwaleed BA; Hayes MC; Cooper AJ; Birch BR
    BJU Int; 2005 May; 95(7):1091-8. PubMed ID: 15839939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Ji BS; He L; Liu GQ
    Life Sci; 2005 Sep; 77(18):2221-32. PubMed ID: 15967469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous determination of cytotoxic (adriamycin, vincristine) and modulator of resistance (verapamil, S 9788) drugs in human cells by high-performance liquid chromatography and ultraviolet detection.
    Tassin JP; Dubois J; Atassi G; Hanocq M
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 691(2):449-56. PubMed ID: 9174283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells.
    Maraldi NM; Zini N; Santi S; Scotlandi K; Serra M; Baldini N
    Biol Cell; 1999 Jan; 91(1):17-28. PubMed ID: 10321019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative 99mTc-sestamibi and 3H-daunomycin uptake in human carcinoma cells: relation to the MDR phenotype and effects of reversing agents.
    Cayre A; Moins N; Finat-Duclos F; Maublant J; Verrelle P
    J Nucl Med; 1999 Apr; 40(4):672-6. PubMed ID: 10210228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of BN Nanoparticles Loaded with Doxorubicin on Tumor Cells with Multiple Drug Resistance.
    Zhitnyak IY; Bychkov IN; Sukhorukova IV; Kovalskii AM; Firestein KL; Golberg D; Gloushankova NA; Shtansky DV
    ACS Appl Mater Interfaces; 2017 Sep; 9(38):32498-32508. PubMed ID: 28857548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Quantitative cytological study of the activity of a new resistance modulator, S 9788, on human leukemic cells using multiparametric image analysis].
    Oum'Hamed Z; Berlion M; Millot-Broglio C; Dufer J; Joly P; Bizzari JP; Desplaces A
    Bull Cancer; 1994 Mar; 81(3):203-11. PubMed ID: 7894128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative evaluation of S9788, verapamil, and cyclosporine A in K562 human leukemia cell lines and in P-glycoprotein-expressing samples from patients with hematologic malignancies.
    Merlin JL; Guerci A; Marchal S; Missoum N; Ramacci C; Humbert JC; Tsuruo T; Guerci O
    Blood; 1994 Jul; 84(1):262-9. PubMed ID: 7912556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversion of P-glycoprotein-mediated multidrug resistance by guggulsterone in multidrug-resistant human cancer cell lines.
    Xu HB; Xu LZ; Li L; Fu J; Mao XP
    Eur J Pharmacol; 2012 Nov; 694(1-3):39-44. PubMed ID: 22960326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.